UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clustering of Tadalafil API Samples According to their Manufacturer in the Context of API Falsification Detection

Journal of pharmaceutical sciences, 2023-11, Vol.112 (11), p.2834-2842

2023

Volltextzugriff (PDF)

Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington’s disease mice

Neurobiology of disease, 2007-11, Vol.28 (2), p.197-205

2007

Volltextzugriff (PDF)

A new synthetic approach of N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide (JTC-801) and its analogues and their pharmacological evaluation as nociceptin receptor (NOP) antagonists

European journal of medicinal chemistry, 2004-12, Vol.39 (12), p.1047-1057

2004

Volltextzugriff (PDF)

Insight from an Italian Delphi Consensus on EVAR feasibility outside the instruction for use: the SAFE EVAR Study

Journal of cardiovascular surgery, 2024-02, Vol.65 (3)

2024

Volltextzugriff (PDF)

Secondary endovascular procedures improve overall patency and limb salvage in patients undergoing in situ saphenous vein infragenicular bypass

Journal of cardiovascular surgery, 2023-08, Vol.64 (4), p.430

2023

Volltextzugriff (PDF)

Synthesis of pyrazolo[1,5-a]-, 1,2,4-triazolo[1,5-a]- and imidazo[1,2-a]pyrimidines related to zaleplon, a new drug for the treatment of insomnia

Journal of heterocyclic chemistry, 2001-09, Vol.38 (5), p.1119-1129

2001

Volltextzugriff (PDF)

Safety and effectiveness of a new valvulotome: insights from the LIMBSAVE registry

International angiology, 2019-08, Vol.38 (4), p.299

2019

Volltextzugriff (PDF)

Comparison of long occlusive femoro-popliteal de novo vs. previous endovascularly treated lesions managed with in situ saphenous bypass

Journal of vascular surgery, 2022-05

2022

Volltextzugriff (PDF)

Current Developments of A2a Adenosine Receptor Antagonists

Current medicinal chemistry, 1995-10, Vol.2 (3), p.707-722

1995

Volltextzugriff (PDF)

Synthesis of imidazo[1,2-c]pyrazolo[4,3-e]pyrimidines, pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines and 1,2,4-triazolo[5,1-i]purines: new potent adenosine A2 receptor antagonists

European journal of medicinal chemistry, 1993, Vol.28 (7-8), p.569-576

1993

Volltextzugriff (PDF)

Synthesis and Evaluation as NOP Ligands of Some Spiro[piperidine-4,2′(1′H)-quinazolin]-4′(3′H)-ones and Spiro[piperidine-4,5′(6′H)-[1,2,4]triazolo[1,5-c]quinazolines]

Chemical and Pharmaceutical Bulletin, 2006, Vol.54(5), pp.611-622

2006

Volltextzugriff (PDF)

Synthesis of bicyclic azacompounds (3-dimethylcarbamoyloxyphenyl) substituted as acetylcholinesterase inhibitors

Journal of heterocyclic chemistry, 2000-07, Vol.37 (4), p.799-810

2000

Volltextzugriff (PDF)

Synthesis and Pharmacological Evaluation of 1,2-Dihydrospiro[isoquinoline-4(3H),4′-piperidin]-3-ones as Nociceptin Receptor Agonists

Journal of medicinal chemistry, 2008-02, Vol.51 (4), p.1058-1062

2008

Volltextzugriff (PDF)

(E)-1-(Heterocyclyl or cyclohexyl)-2-[1,3,7-trisubstituted (xanthin-8-yl)] ethenes as A2a adenosine receptor antagonists

European journal of medicinal chemistry, 1996, Vol.31 (1), p.59-63

1996

Volltextzugriff (PDF)

High resolution NMR conformational studies of new bivalent NOP receptor antagonists in model membrane systems

Bioorganic chemistry, 2011-02, Vol.39 (1), p.59-66

2011

Volltextzugriff (PDF)

Behavioral and electrophysiological effects of the adenosine A 2A receptor antagonist SCH 58261 in R6/2 Huntington’s disease mice

Neurobiology of disease, 2007, Vol.28 (2), p.197-205

2007

Volltextzugriff (PDF)

Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease

European journal of medicinal chemistry, 2002-02, Vol.37 (2), p.91-109

2002

Volltextzugriff (PDF)

Synthesis and cholinesterase inhibitory activity of 6-, 7-methoxy-(and hydroxy-) tacrine derivatives

Farmaco (Società chimica italiana : 1989), 1996-11, Vol.51 (11), p.693

1996

Volltextzugriff (PDF)

Synthesis of 1-Methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine Derivatives and Their Evaluation as Muscarinic Receptor Ligands

Archiv der Pharmazie (Weinheim), 2003-06, Vol.336 (3), p.143-154

2003

Volltextzugriff (PDF)

Synthesis of 5-amino-1,2,3,4-tetrahydrobenzo[b][1,7]naphthyridines and 2,3,4,4a,5,6-hexahydrobenzo[c][2,6]naphthyridines

Journal of heterocyclic chemistry, 1998-07, Vol.35 (4), p.915-922

1998

Volltextzugriff (PDF)

Synthesis of 9-amino-, 9-aminomethyl-1,2,3,4-tetrahydro- and 1,2,3,4,5,6,7,8-octahydroacridine derivatives

Journal of heterocyclic chemistry, 1997-11, Vol.34 (6), p.1661-1667

1997

Volltextzugriff (PDF)

New [g]-fused [1,2,4]triazolo[1,5-c]pyrimidines: Synthesis of pyrido[3,2-e] and [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine, pyrimido[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine and [1,2,4]triazolo[1,5-c]pteridine derivatives

Journal of heterocyclic chemistry, 1994-11, Vol.31 (6), p.1503-1507

1994

Volltextzugriff (PDF)

Synthesis of pyrido[2,1-b]- and thiazolo[2,3-b]purines

Journal of heterocyclic chemistry, 1995-11, Vol.32 (6), p.1725-1730

1995

Volltextzugriff (PDF)

Synthesis of [1,2,4]triazoloquinazoline and [1,2,4]-triazolo-1,4-benzodiazepine derivatives

Journal of heterocyclic chemistry, 1993-01, Vol.30 (1), p.11-16

1993

Volltextzugriff (PDF)

( E)-1-(Heterocyclyl or cyclohexyl)-2-[1,3,7-trisubstituted (xanthin-8-yl)] ethenes as A 2a adenosine receptor antagonists

European journal of medicinal chemistry, 1996, Vol.31 (1), p.59-63

1996

Volltextzugriff (PDF)

1 – 25 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(187)
Mit Volltextzugriff
(159)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clustering of Tadalafil API Samples According to their Manufacturer in the Context of API Falsification Detection

Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington’s disease mice

A new synthetic approach of N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide (JTC-801) and its analogues and their pharmacological evaluation as nociceptin receptor (NOP) antagonists

Insight from an Italian Delphi Consensus on EVAR feasibility outside the instruction for use: the SAFE EVAR Study

Secondary endovascular procedures improve overall patency and limb salvage in patients undergoing in situ saphenous vein infragenicular bypass

Synthesis of pyrazolo[1,5-a]-, 1,2,4-triazolo[1,5-a]- and imidazo[1,2-a]pyrimidines related to zaleplon, a new drug for the treatment of insomnia

Safety and effectiveness of a new valvulotome: insights from the LIMBSAVE registry

Comparison of long occlusive femoro-popliteal de novo vs. previous endovascularly treated lesions managed with in situ saphenous bypass

Current Developments of A2a Adenosine Receptor Antagonists

Synthesis of imidazo[1,2-c]pyrazolo[4,3-e]pyrimidines, pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines and 1,2,4-triazolo[5,1-i]purines: new potent adenosine A2 receptor antagonists

Synthesis and Evaluation as NOP Ligands of Some Spiro[piperidine-4,2′(1′H)-quinazolin]-4′(3′H)-ones and Spiro[piperidine-4,5′(6′H)-[1,2,4]triazolo[1,5-c]quinazolines]

Synthesis of bicyclic azacompounds (3-dimethylcarbamoyloxyphenyl) substituted as acetylcholinesterase inhibitors

Synthesis and Pharmacological Evaluation of 1,2-Dihydrospiro[isoquinoline-4(3H),4′-piperidin]-3-ones as Nociceptin Receptor Agonists

(E)-1-(Heterocyclyl or cyclohexyl)-2-[1,3,7-trisubstituted (xanthin-8-yl)] ethenes as A2a adenosine receptor antagonists

High resolution NMR conformational studies of new bivalent NOP receptor antagonists in model membrane systems

Behavioral and electrophysiological effects of the adenosine A 2A receptor antagonist SCH 58261 in R6/2 Huntington’s disease mice

Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease

Synthesis and cholinesterase inhibitory activity of 6-, 7-methoxy-(and hydroxy-) tacrine derivatives

Synthesis of 1-Methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine Derivatives and Their Evaluation as Muscarinic Receptor Ligands

Synthesis of 5-amino-1,2,3,4-tetrahydrobenzo[b][1,7]naphthyridines and 2,3,4,4a,5,6-hexahydrobenzo[c][2,6]naphthyridines

Synthesis of 9-amino-, 9-aminomethyl-1,2,3,4-tetrahydro- and 1,2,3,4,5,6,7,8-octahydroacridine derivatives

New [g]-fused [1,2,4]triazolo[1,5-c]pyrimidines: Synthesis of pyrido[3,2-e] and [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine, pyrimido[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine and [1,2,4]triazolo[1,5-c]pteridine derivatives

Synthesis of pyrido[2,1-b]- and thiazolo[2,3-b]purines

Synthesis of [1,2,4]triazoloquinazoline and [1,2,4]-triazolo-1,4-benzodiazepine derivatives

( E)-1-(Heterocyclyl or cyclohexyl)-2-[1,3,7-trisubstituted (xanthin-8-yl)] ethenes as A 2a adenosine receptor antagonists

Suchergebnisse filtern